Analyst consensus rating

Bionano Genomics Analyst Rating: none

Direct answer

Bionano Genomics's consensus rating is none.

1 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $4.00.
Forecast evidence checked November 22, 2026.

Get free Bionano Genomics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$0.82
Average price target
$4.00
High price target
$4.00
Low price target
$4.00
Low target gap
+386.5%
Target upside
+386.5%
High target gap
+386.5%
Target range width
0%
Consensus rating
none
Analysts
1
Evidence date
November 22, 2026
Valid through
November 29, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Bionano Genomics?

Bionano Genomics has a verified none consensus. The same dataset has an average price target of $4.00.

How far are Bionano Genomics's low and high targets from the recorded price?

The low target implies +386.5%, while the high target implies +386.5%.

How many analysts are included in Bionano Genomics's consensus?

The verified consensus includes 1 analysts.

How is Bionano Genomics's target upside or downside calculated?

The average target of $4.00 is divided by the recorded price of $0.82, then one is subtracted to produce +386.5%. This does not guarantee a future return.

When was Bionano Genomics's analyst forecast verified?

The data was verified on 2026-11-22. The dataset is valid through 2026-11-29.